EVALUATION OF ETEST COMBINATION TESTING OF ANTIBIOTICS AGAINST ISOLATES FROM PATIENTS WITH CYSTIC FIBROSIS

被引：0
|
作者：
Warren, T. [1 ]
Tullis, E. [1 ,2 ]
Devlin, H. [1 ,2 ]
Matukas, L. M. [1 ,2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
来源：
PEDIATRIC PULMONOLOGY | 2010年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [31] Evaluation of Etest for susceptibility testing of multidrug resistant isolates of Mycobacterium tuberculosis
    Hazón, MH
    Orozco, MD
    Labrada, LA
    Tovar, R
    Weigle, KA
    Wanger, A
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (12) : 4599 - 4603
  • [32] Epidemiology of Streptococcus agalactiae isolates from cystic fibrosis patients
    Eickel, V.
    Kahl, B.
    Spellerberg, B.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 296 : 109 - 109
  • [33] IN VITRO ACTIVITY OF TEMOCILLIN & TOBRAMYCIN ALONE & IN COMBINATION AGAINST PSEUDOMONAS AERUGINOSA & BURKHOLDERIA CEPACIA COMPLEX ISOLATES CULTURED FROM CYSTIC FIBROSIS PATIENTS
    Einarsson, G.
    Elbaz, E.
    Metwally, L.
    McAuley, M.
    Gilpin, D. F.
    McGrath, S.
    McCaughan, J.
    Moore, J.
    Goldsmith, C.
    Elborn, J. S.
    Tunney, M. M.
    PEDIATRIC PULMONOLOGY, 2010, : 347 - 347
  • [34] ACTIVITIES OF VARIOUS BETA-LACTAMS AND AMINOGLYCOSIDES, ALONE AND IN COMBINATION, AGAINST ISOLATES OF PSEUDOMONAS-AERUGINOSA FROM PATIENTS WITH CYSTIC-FIBROSIS
    SCRIBNER, RK
    MARKS, MI
    WEBER, AH
    TARPAY, MM
    WELCH, DF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (06) : 939 - 943
  • [35] COMPARISON OF FIVE METHODS FOR OXACILLIN SUSCEPTIBILITY TESTING OF Staphylococcus aureus ISOLATES FROM CYSTIC FIBROSIS PATIENTS
    Mimica, Marcelo J.
    Carvalho, Rozane L.
    Berezin, Eitan N.
    Damaceno, Neiva
    Caiaffa-Filho, Helio H.
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2012, 54 (06): : 305 - 306
  • [36] Comparison of agardilution and broth microdilution for the susceptibility testing of Pseudomonas aeruginosa isolates from Cystic Fibrosis patients
    Hogardt, M
    Schmoldt, S
    Götzfried, M
    Heesemann, J
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 232 - 233
  • [37] Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics
    Kapoor, Priya
    Murphy, Philip
    HELIYON, 2018, 4 (03):
  • [38] INVITRO ACTIVITY OF AMILORIDE COMBINED WITH TOBRAMYCIN AGAINST PSEUDOMONAS ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS
    COHN, RC
    JACOBS, M
    ARONOFF, SC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) : 395 - 396
  • [39] Evaluation of antimicrobial susceptibility testing methods for Burkholderia cepacia complex isolates from people with and without cystic fibrosis
    Jorth, Peter
    Manuel, Carmila
    Mclemore, Tracey
    Humphries, Romney M.
    Cole, Nicolynn C.
    Schuetz, Audrey N.
    Garica, Dennis
    Maldonado, Maria
    Rivero, Natasha
    Milesi Galdino, Anna Clara
    Celedonio, Diana
    Lipuma, John J.
    Green, Daniel A.
    Zlosnik, James E. A.
    Traczewski, Maria
    Huse, Holly K.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2025, 63 (02)
  • [40] CHANGING SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA ISOLATES FROM CYSTIC-FIBROSIS PATIENTS WITH THE CLINICAL USE OF NEWER ANTIBIOTICS
    BOSSO, JA
    ALLEN, JE
    MATSEN, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) : 526 - 528
12345